Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy With Immunotherapy
Cancers - Switzerland
doi 10.3390/cancers12030714
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2020
Authors
Publisher
MDPI AG